Table of Contents
Index
- Coagulation Factor VIII
- Coagulation Factor IX
- Coagulation Factor VII
- Von Willebrand Factor (vWF)
- Fibrinogen
- Coagulation Factors V and XI
- Coagulation Factor X
- Coagulation Factor XIII
- Topical Fibrinogen and Thrombin Products
- Topical Thrombin Products
- Prothrombin Complex Concentrates
Corporate Coagulation Factor Product and R&D Pipelines
- About La Merie
- Corporate Coagulation Factor Product and R&D Pipelines
- Abraxis Biosciences
- Amsterdam Molecular Therapeutics
- Angiotech
- Apitope
- Asklepios Biopharmaceutical
- Baxter
- Bayer Schering Pharma
- Bio Products Laboratory (BPL)
- Biogen Idec
- Biotest
- Biovitrum
- Catalyst Biosciences
- China Biologic Products
- Crucell
- CSL
- Ethicon (J&J)
- Genzyme
- Green Cross
- Grifols
- GTC Biotherapeutics
- Haemacure
- Inspiration Biopharmaceuticals
- Intas Biopharmaceuticals
- Ipsen
- Jerini
- Kaketsuken
- Kamada
- Kedrion
- King Pharmaceuticals
- LFB
- Lipoxen
- Maxygen
- MDRNA
- MediVas
- Mochida Pharmaceutical
- National Bioproducts Institute (NBI)
- Nautilus Biotech (HanAll Pharmaceuticals)
- Nektar Therapeutics
- Neose Technologies
- Novo Nordisk
- Nycomed
- Octapharma
- Oxford Biomedica
- Pharming
- ProFibrix
- ProGenetics
- PROLOR Biotech
- Recoly
- Roche
- Sanquin
- Shanghai RAAS
- Sinobiomed
- SK Chemicals
- Talecris Biotherapeutics
- Thrombotargets
- VIRxSYS
- Wyeth
- Zymogenetics
|
Related Report
|